163 related articles for article (PubMed ID: 23395601)
1. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA; Pidala J; Pavletic SZ; Wood W; Jacobsohn D; Arai S; Arora M; Jagasia M; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2014 Mar; 20(3):337-44. PubMed ID: 24315845
[TBL] [Abstract][Full Text] [Related]
3. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.
Im JS; Abraham SC; Saliba RM; Rondon G; Ross WA; Rashid A; Shpall EJ; Popat U; Qazilbash MH; Hosing C; Oran B; Shah N; Tewari P; Nieto Y; Kebriaei P; Champlin RE; Alousi AM
Am J Surg Pathol; 2017 Nov; 41(11):1483-1490. PubMed ID: 28834808
[TBL] [Abstract][Full Text] [Related]
4. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.
Pidala J; Vogelsang G; Martin P; Chai X; Storer B; Pavletic S; Weisdorf DJ; Jagasia M; Cutler C; Palmer J; Jacobsohn D; Arai S; Lee SJ
Haematologica; 2012 Mar; 97(3):451-8. PubMed ID: 22058206
[TBL] [Abstract][Full Text] [Related]
5. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
Pidala J; Chai X; Martin P; Inamoto Y; Cutler C; Palmer J; Weisdorf D; Pavletic S; Arora M; Jagasia M; Jacobsohn D; Lee SJ
Biol Blood Marrow Transplant; 2013 Jun; 19(6):967-72. PubMed ID: 23542686
[TBL] [Abstract][Full Text] [Related]
6. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.
Hamilton BK; Rybicki L; Arai S; Arora M; Cutler CS; Flowers MED; Jagasia M; Martin PJ; Palmer J; Pidala J; Majhail NS; Lee SJ; Khera N
Biol Blood Marrow Transplant; 2018 Feb; 24(2):393-399. PubMed ID: 29032275
[TBL] [Abstract][Full Text] [Related]
7. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
El-Jawahri A; Pidala J; Inamoto Y; Chai X; Khera N; Wood WA; Cutler C; Arora M; Carpenter PA; Palmer J; Flowers M; Weisdorf D; Pavletic S; Jaglowski S; Jagasia M; Lee SJ; Chen YB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1341-8. PubMed ID: 24813171
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
9. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
Ferrara JL; Harris AC; Greenson JK; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Huber E; Landfried K; Akashi K; Vander Lugt M; Reddy P; Chin A; Zhang Q; Hanash S; Paczesny S
Blood; 2011 Dec; 118(25):6702-8. PubMed ID: 21979939
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
[TBL] [Abstract][Full Text] [Related]
11. Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Novitzky-Basso I; AlHayli S; Shin E; Pasic I; Al-Shaibani Z; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Eur J Haematol; 2021 Apr; 106(4):508-519. PubMed ID: 33421199
[TBL] [Abstract][Full Text] [Related]
12. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.
Thepot S; Zhou J; Perrot A; Robin M; Xhaard A; de Latour RP; Ades L; Ribaud P; Petropoulou AD; Porcher R; Socié G
Leukemia; 2010 Nov; 24(11):1852-8. PubMed ID: 20827288
[TBL] [Abstract][Full Text] [Related]
13. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
Palmer J; Chai X; Pidala J; Inamoto Y; Martin PJ; Storer B; Pusic I; Flowers ME; Arora M; Pavletic SZ; Lee SJ
Blood; 2016 Jan; 127(1):160-6. PubMed ID: 26527676
[TBL] [Abstract][Full Text] [Related]
17. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
18. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
[TBL] [Abstract][Full Text] [Related]
19. Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
El-Jawahri A; Pidala J; Khera N; Wood WA; Arora M; Carpenter PA; Palmer J; Flowers ME; Jagasia M; Chen YB; Lee SJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2285-2292. PubMed ID: 30031937
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic disagreement between clinical standard histopathological- and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children.
Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Mattsson J; Gustafsson B; Casswall TH
Pediatr Transplant; 2020 Dec; 24(8):e13824. PubMed ID: 33085820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
